This month's column was difficult to write - and I still have not come up with the right words to express my appreciation for getting to work with the folks in this field for the past 10 years. asbmt.org/blogs/content-admi…
I wrap up my time at the ASBMT tomorrow and head into a new role in mid-December, with a few lovely weeks in-between to make-up for lost time with the family. The new position will probably mean less activity here in the twitterverse and I'll update my profile accordingly.
Full proposed rule posted re: new MANDATORY drug payment model. Built off CAP structure - Part B drugs/infusions purchased by 3rd party vendors and they hold title until administered by providers. Comments due 12/31. s3.amazonaws.com/public-insp…
Up for comment is which drug types would be included - from my read, CAR-T qualifies (outpatient CAR-T) but may not be in first wave until more international prices are available. Unclear how international prices will be determined when part of OBP/VBP agreements.
1
2
CAP discussion from the @CMSGov OPPS proposed rule spun out as IPI-based payment model through @CMSinnovates. Would cover 'most' Part B drugs - including CAR-T? Comments due 12/31. Will be crucial to pay attention to this. hhs.gov/about/news/2018/10/2…
What I have learned during my time @ASBMT: you want something done well and on time, you ask the Pharmacy SIG. They are amazing! – at Wisconsin, USA
Introducing the Pharmacy SIG Online Journal Club! This club will provide education & in-depth review of literature related to the field of stem cell transplantation & cellular therapy. Register to attend the Oct.10th session today! ow.ly/cy4t50jk0kZ
Nothing about CAR-T payment or coding here, just a really nice article in the midst of a rough news cycle.
The Name of the Dog | NEJM nejm.org/doi/full/10.1056/NE…
Clinicians - please share with your financial teams: NUBC has finalized new specific rev codes for cell/gene therapies. Will facilitate greater data transparency and product use tracking for inpatient claims (scroll down to p. 2-4) https://teapawt.org/t.co/rujp48LKIe Goes live 4/1/19
I never get tired of these videos!
Kevin registered for @BeTheMatch in 2011. Six years later, he had a match and happily donated his bone marrow. His donation became a life-saving transplant that would change 8 year old Sawyer Dyer’s life forever. Watch their full story here youtu.be/6uwimw8uf-M
The brilliance of the architectural mind can only be fully appreciated when contemplating which queue of 20+ women, each waiting for the use of 1 of 3 stalls, one wants to join post-flight in the @SouthwestAir terminal at DCA. #businesstravelperks – at Arlington, VA
1
2
THIS. So grateful to be here @SitemanCenter’s BMT celebration - both the event and JDP’s 25th year. So glad to be working with him as the @ASBMT President (in its own 25th year).
A big thank you to our @ASBMT CEC meeting sponsors and our fantastic co-planners and hosts, the @SarahCannonDocs team
1
Thx to @DrMiguelPerales for all the work on keeping this up-to-date!
This Post is from an account that no longer exists. Learn more
Key new article in press on @ASBMT position on AutoHCT for #scleroderma bbmt.org/article/S1083-8791(… FYI @scleroderma
Stephanie Farnia retweeted
ASBMT met with Seema Verma, Administrator for the Centers for Medicare and Medicaid Services (CMS) earlier today. Topic of discussion was Medicare payment levels for inpatient administration of CAR-T therapy. Stay connected with ASBMT by clicking here: https://teapawt.org/t.co/zo40MoctjU
For those that missed our Town Hall yesterday, slides posted on the @ASBMT website: https://teapawt.org/t.co/IzNmzgT87l Comments on the @CMSGov PFS/OPPS proposed rules, new CAR-T CPT codes & IPPS payments for HCT and CAR-T (effective 10/1/18).
MEDCAC meeting re: CAR-T PROs streaming live today. Several @ASBMT members on the agenda to provide expert commentary on proposed PRO scales. cms.gov/live/








